{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:10:52Z","timestamp":1791443452586,"version":"4.3.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Graduiertenkolleg 2254"],"award-info":[{"award-number":["Graduiertenkolleg 2254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Graduiertenkolleg 2254"],"award-info":[{"award-number":["Graduiertenkolleg 2254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Graduiertenkolleg 2254"],"award-info":[{"award-number":["Graduiertenkolleg 2254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Graduiertenkolleg 2254"],"award-info":[{"award-number":["Graduiertenkolleg 2254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Graduiertenkolleg 2254"],"award-info":[{"award-number":["Graduiertenkolleg 2254"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hepatocellular carcinoma (HCC) often arises from chronic liver disease, but early biomarkers of malignant transformation are lacking. CD44, a transmembrane glycoprotein with multiple isoforms, has been implicated in cancer progression and immune modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed CD44 expression in mouse models of chronic and acute liver injury and assessed its clinical relevance in human HCC using bulk and single-cell transcriptomic datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CD44 and its isoforms v6 and v10 were progressively upregulated in chronic liver injury, peaking in HCC. CD44-positive hepatocytes increased with fibrosis severity and were abundant in murine liver tumours. In human HCC, CD44 expression was significantly elevated compared to non-tumorous liver and was associated with reduced overall survival. CD44\n                      <jats:sup>high<\/jats:sup>\n                      tumours showed enrichment in oncogenic signalling pathways and greater infiltration of immunosuppressive cells, including M2 macrophages and Th2 cells. Single-cell RNA-seq confirmed CD44 expression in both tumour and immune cells, linking it to a protumor immune microenvironment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CD44 is a promising early biomarker of hepatocarcinogenesis and a potential therapeutic target. Its expression reflects disease progression from fibrosis to cancer and is associated with poor prognosis and immune evasion in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03284-y","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T18:00:15Z","timestamp":1765821615000},"page":"555-566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["CD44 upregulation in chronic liver disease marks the transition to hepatocellular carcinoma and portends poor prognosis"],"prefix":"10.1038","volume":"134","author":[{"given":"Rui","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Srikanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Tharehalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Schirmbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-6959","authenticated-orcid":false,"given":"Andr\u00e9","family":"Lechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"3284_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastro Hepat. 2021;18:223\u201338.","journal-title":"Nat Rev Gastro Hepat"},{"key":"3284_CR2","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1002\/hep.28988","volume":"65","author":"GK Michalopoulos","year":"2017","unstructured":"Michalopoulos GK. Hepatostat: liver regeneration and normal liver tissue maintenance. Hepatology. 2017;65:1384\u201392.","journal-title":"Hepatology"},{"key":"3284_CR3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41590-018-0044-z","volume":"19","author":"M Ringelhan","year":"2018","unstructured":"Ringelhan M, Pfister D, O\u2019Connor T, Pikarsky E, Heikenwalder M. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19:222\u201332.","journal-title":"Nat Immunol"},{"key":"3284_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, De Martel C, Georges D, Ibrahim AS, Zheng R, et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108\u201318.","journal-title":"Eur J Cancer"},{"key":"3284_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"3284_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2019.09.007","volume":"72","author":"O Clements","year":"2020","unstructured":"Clements O, Eliahoo J, Kim JU, Taylor-Robinson SD, Khan SA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72:95\u2013103.","journal-title":"J Hepatol"},{"key":"3284_CR7","doi-asserted-by":"publisher","first-page":"7645","DOI":"10.3748\/wjg.v22.i34.7645","volume":"22","author":"S Colagrande","year":"2016","unstructured":"Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol. 2016;22:7645.","journal-title":"World J Gastroenterol"},{"key":"3284_CR8","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.3390\/ijms25094749","volume":"25","author":"J Han","year":"2024","unstructured":"Han J, Lee C, Jung Y. Current evidence and perspectives of cluster of differentiation 44 in the liver\u2019s physiology and pathology. Int J Mol Sci. 2024;25:4749.","journal-title":"Int J Mol Sci"},{"key":"3284_CR9","doi-asserted-by":"crossref","unstructured":"Jordan AR, Racine RR, Hennig MJP, Lokeshwar VB. The role of CD44 in disease pathophysiology and targeted treatment. Front Immunol [Internet]. [cited 2024 Jul 23];6. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2015.00182\/abstract, 2015.","DOI":"10.3389\/fimmu.2015.00182"},{"key":"3284_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/hep4.1721","volume":"5","author":"Y Osawa","year":"2021","unstructured":"Osawa Y, Kawai H, Tsunoda T, Komatsu H, Okawara M, Tsutsui Y, et al. Cluster of differentiation 44 promotes liver fibrosis and serves as a biomarker in congestive hepatopathy. Hepatol Commun. 2021;5:1437\u201347.","journal-title":"Hepatol Commun"},{"key":"3284_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01840-z","volume":"21","author":"M Razmi","year":"2021","unstructured":"Razmi M, Ghods R, Vafaei S, Sahlolbei M, Saeednejad Zanjani L, Madjd Z. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis. Cancer Cell Int. 2021;21:139.","journal-title":"Cancer Cell Int"},{"key":"3284_CR12","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.3390\/ijms242115812","volume":"24","author":"N Cirillo","year":"2023","unstructured":"Cirillo N. The hyaluronan\/CD44 axis: a double-edged sword in cancer. Int J Mol Sci. 2023;24:15812.","journal-title":"Int J Mol Sci"},{"key":"3284_CR13","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/biomedicines11072077","volume":"11","author":"T Du","year":"2023","unstructured":"Du T, Wu Z, Wu Y, Liu Y, Song Y, Ma L. CD44 is associated with poor prognosis of ccRCC and facilitates ccRCC cell migration and invasion through HAS1\/MMP9. Biomedicines. 2023;11:2077.","journal-title":"Biomedicines"},{"key":"3284_CR14","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1039\/D0CS00379D","volume":"49","author":"J Han","year":"2020","unstructured":"Han J, Won M, Kim JH, Jung E, Min K, Jangili P, et al. Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective. Chem Soc Rev. 2020;49:7856\u201378.","journal-title":"Chem Soc Rev"},{"key":"3284_CR15","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/biom11121850","volume":"11","author":"M Hassn Mesrati","year":"2021","unstructured":"Hassn Mesrati M, Syafruddin SE, Mohtar MA, Syahir A. CD44: A Multifunctional mediator of cancer progression. Biomolecules. 2021;11:1850.","journal-title":"Biomolecules"},{"key":"3284_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06070-9","volume":"23","author":"Y Yang","year":"2025","unstructured":"Yang Y, Sun H, Yu H, Wang L, Gao C, Mei H, et al. Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression. J Transl Med. 2025;23:123.","journal-title":"J Transl Med"},{"key":"3284_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ccell.2018.05.003","volume":"33","author":"D Dhar","year":"2018","unstructured":"Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, et al. Liver cancer initiation requires p53 inhibition by CD44-enhanced growth factor signaling. Cancer Cell. 2018;33:1061\u2013.e6.","journal-title":"Cancer Cell"},{"key":"3284_CR18","doi-asserted-by":"crossref","unstructured":"Senbanjo LT, Chellaiah MA. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front Cell Dev Biol [Internet]. [cited 2024 Jul 31];5. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fcell.2017.00018\/full, 2017.","DOI":"10.3389\/fcell.2017.00018"},{"key":"3284_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64.","journal-title":"J Hematol Oncol"},{"key":"3284_CR20","doi-asserted-by":"publisher","first-page":"6909","DOI":"10.1073\/pnas.84.19.6909","volume":"84","author":"FV Chisari","year":"1987","unstructured":"Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci USA. 1987;84:6909\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3284_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1099\/vir.0.19724-0","volume":"85","author":"T Alonzi","year":"2004","unstructured":"Alonzi T, Agrati C, Costabile B, Cicchini C, Amicone L, Cavallari C, et al. Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol. 2004;85:1509\u201320.","journal-title":"J Gen Virol"},{"key":"3284_CR22","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/cancers11101410","volume":"11","author":"M Svinarenko","year":"2019","unstructured":"Svinarenko M, Katz S-F, Tharehalli U, Mulaw MA, Maier HJ, Sunami Y, et al. An IKK\/NF-\u03baB activation\/p53 deletion sequence drives liver carcinogenesis and tumor differentiation. Cancers. 2019;11:1410.","journal-title":"Cancers"},{"key":"3284_CR23","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3390\/ijms19123801","volume":"19","author":"U Tharehalli","year":"2018","unstructured":"Tharehalli U, Svinarenko M, Kraus JM, K\u00fchlwein SD, Szekely R, Kiesle U, et al. YAP activation drives liver regeneration after cholestatic damage induced by Rbpj deletion. Int J Mol Sci. 2018;19:3801.","journal-title":"Int J Mol Sci"},{"key":"3284_CR24","first-page":"186","volume":"12","author":"GM Higgins","year":"1931","unstructured":"Higgins GM, Anderson RM. Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal. Arch Pathol. 1931;12:186\u2013202.","journal-title":"Arch Pathol"},{"key":"3284_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/0023677215572000","volume":"49","author":"Y Nevzorova","year":"2015","unstructured":"Nevzorova Y, Tolba R, Trautwein C, Liedtke C. Partial hepatectomy in mice. Lab Anim. 2015;49:81\u20138.","journal-title":"Lab Anim"},{"key":"3284_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.274.1.305","volume":"274","author":"C Postic","year":"1999","unstructured":"Postic C, Shiota M, Niswender KD, Jetton TL, Chen Y, Moates JM, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic \u03b2 cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274:305\u201315.","journal-title":"J Biol Chem"},{"key":"3284_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1101\/gad.14.8.994","volume":"14","author":"S Marino","year":"2000","unstructured":"Marino S, Vooijs M, Van Der Gulden H, Jonkers J, Berns A. Induction of medulloblastomas in p53 -null mutant mice by somatic inactivation of rb in the external granular layer cells of the cerebellum. Genes Dev. 2000;14:994\u20131004.","journal-title":"Genes Dev"},{"key":"3284_CR28","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3284_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon J-C, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17:174.","journal-title":"Genome Biol"},{"key":"3284_CR30","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"3284_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"3284_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3284_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinf. 2013;14:7.","journal-title":"BMC Bioinf"},{"key":"3284_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J Integr Biol. 2012;16:284\u20137.","journal-title":"OMICS J Integr Biol"},{"key":"3284_CR35","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han Y, Wang Y, Dong X, Sun D, Liu Z, Yue J, et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 2023;51:D1425\u201331.","journal-title":"Nucleic Acids Res"},{"key":"3284_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"3284_CR37","doi-asserted-by":"crossref","unstructured":"Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor\u2013immune system interactions. Wren J, editor. Bioinformatics. 2019;35:4200\u20132.","DOI":"10.1093\/bioinformatics\/btz210"},{"key":"3284_CR38","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3892\/or.2024.8831","volume":"52","author":"O Sherif","year":"2024","unstructured":"Sherif O, Khelwatty S, Bagwan I, Seddon A, Dalgleish A, Mudan S, et al. Expression of EGFRvIII and its co\u2011expression with wild\u2011type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma. Oncol Rep. 2024;52:172.","journal-title":"Oncol Rep"},{"key":"3284_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"D-Z Guo","year":"2024","unstructured":"Guo D-Z, Zhang X, Zhang S-Q, Zhang S-Y, Zhang X-Y, Yan J-Y, et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol Cancer. 2024;23:157.","journal-title":"Mol Cancer"},{"key":"3284_CR40","doi-asserted-by":"publisher","first-page":"12061","DOI":"10.3390\/ijms232012061","volume":"23","author":"H Zhu","year":"2022","unstructured":"Zhu H, Zhou W, Wan Y, Lu J, Ge K, Jia C. CD44V3, an alternatively spliced form of CD44, promotes pancreatic cancer progression. Int J Mol Sci. 2022;23:12061.","journal-title":"Int J Mol Sci"},{"key":"3284_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0168-8278(00)80192-0","volume":"32","author":"K Endo","year":"2000","unstructured":"Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol. 2000;32:78\u201384.","journal-title":"J Hepatol"},{"key":"3284_CR42","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.2147\/IJGM.S306339","volume":"14","author":"A Titapun","year":"2021","unstructured":"Titapun A, Luvira V, Srisuk T, Jareanrat A, Thanasukarn V, Thanee M, et al. High levels of serum IgG for Opisthorchis viverrini and CD44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection. Int J Gen Med. 2021;14:2191\u2013204.","journal-title":"Int J Gen Med"},{"key":"3284_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"3284_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02717-5","volume":"22","author":"P Su","year":"2022","unstructured":"Su P, Jiang L, Zhang Y, Yu T, Kang W, Liu Y, et al. Crosstalk between tumor-associated macrophages and tumor cells promotes chemoresistance via CXCL5\/PI3K\/AKT\/mTOR pathway in gastric cancer. Cancer Cell Int. 2022;22:290.","journal-title":"Cancer Cell Int"},{"key":"3284_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764596","volume":"12","author":"A Frafjord","year":"2021","unstructured":"Frafjord A, Buer L, Hammarstr\u00f6m C, Aamodt H, Woldb\u00e6k PR, Brustugun OT, et al. The immune landscape of human primary lung tumors is Th2 skewed. Front Immunol. 2021;12:764596.","journal-title":"Front Immunol"},{"key":"3284_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115976","volume":"170","author":"Q Shang","year":"2024","unstructured":"Shang Q, Yu X, Sun Q, Li H, Sun C, Liu L. Polysaccharides regulate Th1\/Th2 balance: a new strategy for tumor immunotherapy. Biomed Pharmacother. 2024;170:115976.","journal-title":"Biomed Pharmacother"},{"key":"3284_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.101041","volume":"73","author":"H Wang","year":"2024","unstructured":"Wang H, Wang X, Zhang X, Xu W. The promising role of tumor-associated macrophages in the treatment of cancer. Drug Resist Updat. 2024;73:101041.","journal-title":"Drug Resist Updat"},{"key":"3284_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116014","volume":"170","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Qian M, Li J, Ruan L, Wang Y, Cai C, et al. The role of tumor-associated macrophages in lung cancer: from mechanism to small molecule therapy. Biomed Pharmacother. 2024;170:116014.","journal-title":"Biomed Pharmacother"},{"key":"3284_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05613-w","volume":"22","author":"W Tong","year":"2024","unstructured":"Tong W, Wang T, Bai Y, Yang X, Han P, Zhu L, et al. Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment. J Transl Med. 2024;22:840.","journal-title":"J Transl Med"},{"key":"3284_CR50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/1097-0142(20010815)92:4<713::AID-CNCR1374>3.0.CO;2-O","volume":"92","author":"S Molica","year":"2001","unstructured":"Molica S, Vitelli G, Levato D, Giannarelli D, Gandolfo GM. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression. Cancer. 2001;92:713\u20139.","journal-title":"Cancer"},{"key":"3284_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133625","volume":"275","author":"AH Mohammadi","year":"2024","unstructured":"Mohammadi AH, Bagheri F, Baghaei K. Chondroitin sulfate-tocopherol succinate modified exosomes for targeted drug delivery to CD44-positive cancer cells. Int J Biol Macromol. 2024;275:133625.","journal-title":"Int J Biol Macromol"},{"key":"3284_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119122","volume":"578","author":"J Li","year":"2020","unstructured":"Li J, Li M, Tian L, Qiu Y, Yu Q, Wang X, et al. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. Int J Pharm. 2020;578:119122.","journal-title":"Int J Pharm"},{"key":"3284_CR53","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.3390\/ijms24044007","volume":"24","author":"R Ejima","year":"2023","unstructured":"Ejima R, Suzuki H, Tanaka T, Asano T, Kaneko MK, Kato Y. Development of a novel anti-CD44 variant 6 monoclonal antibody C44Mab-9 for multiple applications against colorectal carcinomas. Int J Mol Sci. 2023;24:4007.","journal-title":"Int J Mol Sci"},{"key":"3284_CR54","unstructured":"Li J-H, Wang Y-C, Qin C-D, Yao R-R, Zhang R, Wang Y, et al. Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation. Am J Cancer Res. 2016;6:509\u201321."},{"key":"3284_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1469827","volume":"15","author":"Z Su","year":"2024","unstructured":"Su Z, Zhong Y, He Y, You L, Xin F, Wang L, et al. Bulk- and single cell-RNA sequencing reveal KIF20A as a key driver of hepatocellular carcinoma progression and immune evasion. Front Immunol. 2024;15:1469827.","journal-title":"Front Immunol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03284-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:03:00Z","timestamp":1769774580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2,20]]}},"alternative-id":["3284"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03284-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments were conducted in accordance with the relevant institutional guidelines and regulations. Animal related experiments were conducted as per the ARRIVE reporting guidelines 2.0 and in accordance with the protocol approved by the Animal Care Committee of the University of Ulm and the Federal Authorities for Animal Research (protocol number 35\/9185.81-3, Regierungspraesidium Tuebingen, Baden-Wuerttemberg, Germany). The human data analysed in this study were obtained exclusively from publicly accessible databases, including The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and the Human Protein Atlas (HPA) portal. The IHC images downloaded from the HPA are fully anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}